Ashby, Damien

Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin

Ashby, D. R., Gale, D. P., Busbridge, M., Murphy, K. G., Duncan, N. D., Cairns, T. D., Taube, D. H., Bloom, S. R., Tam, F. W. K., Chapman, R., et al. (2010) · Haematologica

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 191

Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids

Prendecki, M., Tanna, A., Salama, A. D., Tam, F. W. K., Cairns, T., Taube, D., Cook, H. T., Ashby, D., Duncan, N. D., & Pusey, C. D. (2016) · Clinical Kidney Journal

Acute Kidney Injury ResearchRenal Diseases and Glomerulopathies

Cited by 63

UK Kidney Association Clinical Practice Guideline on vascular access for haemodialysis

Aitken, E., Anijeet, H., Ashby, D., Barrow, W., Calder, F., Dowds, B., Fielding, C., Gilbert, J., Jones, R., Karunanithy, N., et al. (2025) · BMC Nephrology

Central Venous Catheters and HemodialysisDialysis and Renal Disease Management

Cited by 42